Press Releases InMed Announces Agreement to Advance a Topical Formulation of INM-750 June 13, 2017 Read More » InMed Raises $5.75 Million Through Underwritten Financing Including Full Exercise of the Over-Allotment Option May 31, 2017 Read More » InMed Announces Pricing of $5,004,000 Underwritten Financing May 23, 2017 Read More » InMed Pharmaceuticals Files Provisional Patent Application for Ophthalmic Drug Delivery May 10, 2017 Read More » InMed Pharmaceuticals Announces Marketed Offering of Common Shares April 21, 2017 Read More » InMed Pharmaceuticals Shareholders Approve New Stock Option Plan and Articles March 24, 2017 Read More » InMed Pharmaceuticals to Present at the 29th Annual ROTH Conference March 8, 2017 Read More » InMed Pharmaceuticals Files PCT Patent for Epidermolysis Bullosa Simplex March 2, 2017 Read More » InMed Receives over $1,350,000 From Warrant Exercise February 27, 2017 Read More » InMed Pharmaceuticals to Present at the 2017 BIO CEO & Investor Conference February 9, 2017 Read More » InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for C$1,500,000 January 18, 2017 Read More » InMed Pharmaceuticals Appoints Martin Bott to Board of Directors January 13, 2017 Read More » InMed Launches New Website January 9, 2017 Read More » InMed Pharmaceuticals, Inc. Announces Non-Brokered Private Placement of C$1,000,000 January 9, 2017 Read More » InMed Provides 2016 Year End Update December 23, 2016 Read More » InMed Pharmaceuticals Announces Appointment of Veteran Biotech CFO, Jeff Charpentier December 15, 2016 Read More » InMed announces progress on COPD program December 6, 2016 Read More » InMed to Present at Cannabis-Based Therapies Conference November 23, 2016 Read More » InMed Pharmaceuticals, Inc. Appoints Senior Vice President, Clinical and Regulatory Affairs October 31, 2016 Read More » InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for C$1,500,000 October 27, 2016 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Next » Management Learn More Board of Directors Learn More Scientific Advisory Board Learn More Investor Alerts Sign up to receive news releases from InMed Pharmaceuticals. SIGN UP
InMed Raises $5.75 Million Through Underwritten Financing Including Full Exercise of the Over-Allotment Option May 31, 2017 Read More »
InMed Pharmaceuticals Files Provisional Patent Application for Ophthalmic Drug Delivery May 10, 2017 Read More »
InMed Pharmaceuticals Shareholders Approve New Stock Option Plan and Articles March 24, 2017 Read More »
InMed Pharmaceuticals to Present at the 2017 BIO CEO & Investor Conference February 9, 2017 Read More »
InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for C$1,500,000 January 18, 2017 Read More »
InMed Pharmaceuticals, Inc. Announces Non-Brokered Private Placement of C$1,000,000 January 9, 2017 Read More »
InMed Pharmaceuticals Announces Appointment of Veteran Biotech CFO, Jeff Charpentier December 15, 2016 Read More »
InMed Pharmaceuticals, Inc. Appoints Senior Vice President, Clinical and Regulatory Affairs October 31, 2016 Read More »
InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for C$1,500,000 October 27, 2016 Read More »
